Rico-Mendez M, Trujillo-Rojas M, Ayala-Madrigal M, Hernandez-Sandoval J, Gonzalez-Mercado A, Gutierrez-Angulo M
Genes (Basel). 2025; 16(2).
PMID: 40004511
PMC: 11854980.
DOI: 10.3390/genes16020182.
Zhou R, Li L, Ou Q, Wang Y, Fang Y, Zhang C
Biomolecules. 2025; 15(1).
PMID: 39858498
PMC: 11763947.
DOI: 10.3390/biom15010104.
Tan X, Fang Y, Fan X, Deng W, Huang J, Cai Y
Gastroenterol Rep (Oxf). 2024; 12:goae011.
PMID: 38566849
PMC: 10985700.
DOI: 10.1093/gastro/goae011.
Hitchins M, Damaso E, Alvarez R, Zhou L, Hu Y, Diniz M
J Natl Compr Canc Netw. 2023; 21(7):743-752.e11.
PMID: 37433431
PMC: 11578100.
DOI: 10.6004/jnccn.2023.7020.
Joo J, Mahmood K, Walker R, Georgeson P, Candiloro I, Clendenning M
Clin Epigenetics. 2023; 15(1):95.
PMID: 37270516
PMC: 10239107.
DOI: 10.1186/s13148-023-01511-y.
MLH1-methylated endometrial cancer under 60 years of age as the "sentinel" cancer in female carriers of high-risk constitutional MLH1 epimutation.
Hitchins M, Alvarez R, Zhou L, Aguirre F, Damaso E, Pineda M
Gynecol Oncol. 2023; 171:129-140.
PMID: 36893489
PMC: 10153467.
DOI: 10.1016/j.ygyno.2023.02.017.
Concurrent loss of MLH1, PMS2 and MSH6 immunoexpression in digestive system cancers indicating a widespread dysregulation in DNA repair processes.
Reitsam N, Markl B, Dintner S, Waidhauser J, Vlasenko D, Grosser B
Front Oncol. 2022; 12:1019798.
PMID: 36387226
PMC: 9643848.
DOI: 10.3389/fonc.2022.1019798.
Epigenetic alterations induced by genotoxic occupational and environmental human chemical carcinogens: An update of a systematic literature review.
Goodman S, Chappell G, Guyton K, Pogribny I, Rusyn I
Mutat Res Rev Mutat Res. 2022; 789:108408.
PMID: 35690411
PMC: 9188653.
DOI: 10.1016/j.mrrev.2021.108408.
Testing for Lynch Syndrome in Endometrial Carcinoma: From Universal to Age-Selective Methylation Analysis.
Pasanen A, Loukovaara M, Kaikkonen E, Olkinuora A, Pylvanainen K, Alhopuro P
Cancers (Basel). 2022; 14(5).
PMID: 35267656
PMC: 8909331.
DOI: 10.3390/cancers14051348.
Methylation Serves as a Prognostic Biomarker and Associates with Immune Cell Infiltration and Immune Checkpoint Blockade Response in Lower-Grade Glioma.
Noor H, Zaman A, Teo C, Sughrue M
Int J Mol Sci. 2021; 22(22).
PMID: 34830454
PMC: 8625785.
DOI: 10.3390/ijms222212572.
Interaction between Microsatellite Instability (MSI) and Tumor DNA Methylation in the Pathogenesis of Colorectal Carcinoma.
Jasmine F, Haq Z, Kamal M, Raza M, da Silva G, Gorospe K
Cancers (Basel). 2021; 13(19).
PMID: 34638440
PMC: 8508563.
DOI: 10.3390/cancers13194956.
promoter hypermethylation predicts poorer prognosis in mismatch repair deficiency endometrial carcinomas.
Kaneko E, Sato N, Sugawara T, Noto A, Takahashi K, Makino K
J Gynecol Oncol. 2021; 32(6):e79.
PMID: 34431253
PMC: 8550932.
DOI: 10.3802/jgo.2021.32.e79.
Development and external validation of a novel nomogram for screening Chinese Lynch syndrome: based on a multicenter, population study.
Yang M, Li D, Jiang W, Zhu L, Ju H, Sun Y
Ther Adv Med Oncol. 2021; 13:17588359211023290.
PMID: 34178123
PMC: 8207298.
DOI: 10.1177/17588359211023290.
Comparison of microsatellite instability detection by immunohistochemistry and molecular techniques in colorectal and endometrial cancer.
Dedeurwaerdere F, Bm Claes K, Van Dorpe J, Rottiers I, Van der Meulen J, Breyne J
Sci Rep. 2021; 11(1):12880.
PMID: 34145315
PMC: 8213758.
DOI: 10.1038/s41598-021-91974-x.
Clinical and epigenetic features of colorectal cancer patients with somatic POLE proofreading mutations.
Kawai T, Nyuya A, Mori Y, Tanaka T, Tanioka H, Yasui K
Clin Epigenetics. 2021; 13(1):117.
PMID: 34034807
PMC: 8146650.
DOI: 10.1186/s13148-021-01104-7.
Identification of two methylated fragments of an SDC2 CpG island using a sliding window technique for early detection of colorectal cancer.
Li R, Qu B, Wan K, Lu C, Li T, Zhou F
FEBS Open Bio. 2021; 11(7):1941-1952.
PMID: 33955718
PMC: 8255834.
DOI: 10.1002/2211-5463.13180.
Diagnosis of Lynch Syndrome and Strategies to Distinguish Lynch-Related Tumors from Sporadic MSI/dMMR Tumors.
Leclerc J, Vermaut C, Buisine M
Cancers (Basel). 2021; 13(3).
PMID: 33530449
PMC: 7865821.
DOI: 10.3390/cancers13030467.
How Should We Test for Lynch Syndrome? A Review of Current Guidelines and Future Strategies.
Gallon R, Gawthorpe P, Phelps R, Hayes C, Borthwick G, Santibanez-Koref M
Cancers (Basel). 2021; 13(3).
PMID: 33499123
PMC: 7865939.
DOI: 10.3390/cancers13030406.
Discordant DNA mismatch repair protein status between synchronous or metachronous gastrointestinal carcinomas: frequency, patterns, and molecular etiologies.
Vyas M, Firat C, Hechtman J, Weiser M, Yaeger R, Vanderbilt C
Fam Cancer. 2020; 20(3):201-213.
PMID: 33033905
PMC: 8032798.
DOI: 10.1007/s10689-020-00210-4.
Molecular Basis of Mismatch Repair Protein Deficiency in Tumors from Lynch Suspected Cases with Negative Germline Test Results.
Olkinuora A, Gylling A, Almusa H, Eldfors S, Lepisto A, Mecklin J
Cancers (Basel). 2020; 12(7).
PMID: 32660107
PMC: 7408769.
DOI: 10.3390/cancers12071853.